Turnstone Biologics Statistics

Total Valuation

TSBX has a market cap or net worth of $70.54 million. The enterprise value is -$21.14 million.

Market Cap	70.54M
Enterprise Value	-21.14M

Important Dates

The next estimated earnings date is Monday, May 20, 2024, before market open.

Earnings Date	May 20, 2024
Ex-Dividend Date	n/a

Share Statistics

TSBX has 23.13 million shares outstanding. The number of shares has increased by 365.39% in one year.

Shares Outstanding	23.13M
Shares Change (YoY)	+365.39%
Shares Change (QoQ)	-33.54%
Owned by Insiders (%)	5.14%
Owned by Institutions (%)	62.24%
Float	14.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.65
Forward PS	n/a
PB Ratio	0.71
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.57, with a Debt / Equity ratio of 0.03.

Current Ratio	8.57
Quick Ratio	7.94
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-53.70%
Return on Capital (ROIC)	-57.94%
Revenue Per Employee	$241,325
Profits Per Employee	-$690,488
Employee Count	80
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	-286,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.10
200-Day Moving Average	4.15
Relative Strength Index (RSI)	52.35
Average Volume (30 Days)	181,991

Short Selling Information

The latest short interest is 690,690, so 2.99% of the outstanding shares have been sold short.

Short Interest	690,690
Short Previous Month	629,870
Short % of Shares Out	2.99%
Short % of Float	4.91%
Short Ratio (days to cover)	2.73

Income Statement

In the last 12 months, TSBX had revenue of $19.31 million and -$55.24 million in losses. Loss per share was -$4.78.

Revenue	19.31M
Gross Profit	19.31M
Operating Income	-59.03M
Pretax Income	-55.49M
Net Income	-55.24M
EBITDA	-52.69M
EBIT	-55.49M
Loss Per Share	-$4.78

Full Income Statement

Balance Sheet

The company has $94.89 million in cash and $3.21 million in debt, giving a net cash position of $91.68 million or $3.96 per share.

Cash & Cash Equivalents	94.89M
Total Debt	3.21M
Net Cash	91.68M
Net Cash Per Share	$3.96
Equity / Book Value	98.67M
Book Value Per Share	4.27
Working Capital	90.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$66.15 million and capital expenditures -$797,000, giving a free cash flow of -$66.95 million.

Operating Cash Flow	-66.15M
Capital Expenditures	-797,000
Free Cash Flow	-66.95M
FCF Per Share	-$5.79

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -305.77% and -286.12%.

Gross Margin	100.00%
Operating Margin	-305.77%
Pretax Margin	-287.40%
Profit Margin	-286.12%
EBITDA Margin	-272.91%
EBIT Margin	-287.40%
FCF Margin	-346.78%

Dividends & Yields

TSBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-365.39%
Shareholder Yield	-365.39%
Earnings Yield	-78.31%
FCF Yield	-94.91%

Analyst Forecast

The average price target for TSBX is $19.00, which is 522.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.00
Price Target Difference	522.95%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSBX has an Altman Z-Score of 0.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.31
Piotroski F-Score	2